H.R.2114 - Block Organ Transplant Purchases from China Act of 2025 (119th Congress)
Summary
H.R.2114, also known as the Block Organ Transplant Purchases from China Act of 2025, aims to prevent the purchase and provision of organs from China by amending the Social Security Act, Public Health Service Act, and the National Organ Transplant Act. The bill prohibits Medicare, Medicaid, and group health plans from covering organ transplants performed in China or using organs not procured through the established Organ Procurement and Transplantation Network. It also imposes criminal and civil penalties on healthcare providers who violate these prohibitions, starting January 1, 2026.
Expected Effects
The bill will likely reduce or eliminate the ability of US citizens to receive organ transplants in China or using organs sourced outside the established US network. This could potentially increase demand for organs within the US system and may impact the availability of organs for all patients. Healthcare providers will face legal repercussions for non-compliance.
Potential Benefits
- Potentially reduces unethical organ harvesting practices in China.
- Strengthens the integrity of the US organ donation and transplantation system.
- Protects US patients from unknowingly participating in unethical medical practices.
- May increase awareness of organ donation within the US.
- Could improve international perception of US ethical standards in healthcare.
Potential Disadvantages
- Limits options for patients needing organ transplants, potentially increasing wait times and mortality.
- May create financial burdens for patients seeking transplants outside of covered US systems.
- Could strain the existing US organ donation system if demand increases significantly.
- Potential for legal challenges regarding patient rights and access to medical care.
- May negatively impact diplomatic relations with China.
Constitutional Alignment
The bill aligns with the general welfare clause of the Constitution by aiming to protect citizens from unethical medical practices. However, potential challenges could arise under the due process clause if the restrictions unduly limit access to life-saving medical treatments. The federal government's power to regulate interstate and foreign commerce is relevant here, as it pertains to the procurement and transplantation of organs across state and international lines.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).